Huntington Bancshares Incorporated (HBAN): what the price requires

At today's price, Huntington Bancshares Incorporated (HBAN) is priced for 12.7% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/HBAN

Headline

FieldValue
TickerHBAN
CompanyHuntington Bancshares Incorporated
Current price$17.93/sh
CompositionConsumer & Regional Banking 66% / Commercial Banking 34%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Elite ROE must persist for30.3y before normalizing (held at the 12.4% elite tier)
Perpetuity-equivalent ROE12.7%
Return on equity now9.7%
ROE gap+3.0pp
Price-to-book1.23x

Solve inputs: computed at a 11.1% cost of equity; ROE searched up to the 12.4% ROE ceiling.

Reconcile: at the x-ray's 9.3% required return this reads ~10.4%; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history+1.14σ
cohort percentile (of 119 peers)32
sustained it ~10 years at this level68%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.43x3expensive
Earnings1.50x2expensive
Relative1.15x3expensive
Growth0.95x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.2%); the inversion above states its own rate.

Per-Model Detail (n=11)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$5.633.19xyesTBVPS $11.60 × 0.49x (ROE (TTM) 6.8% / CoE 9.3%, g=4.4% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.75% allowance/loans → ×0.98, NPL 0.72% → ×0.99)
Relative ValuationRelative$15.831.13xyesP/E 11.64x (blended: static sector reference 10x + trailing (TTM) 15x), scenarios: 9.5x / 11.6x / 13.8x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth$22.600.79xyesDPS $0.52, g=6.8% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$8.242.18xyesStage 1: 1% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$12.551.43xyesBV/sh $17.12, ROE (TTM) 6.8%, ke 9.3%
Two-Stage Excess ReturnAsset$10.631.69xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$18.890.95xyesRev $6.5B, growth 18% (input: historical growth; tapered), Terminal P/S: 4.3x / 5.3x / 6.3x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$15.601.15xyesEPS $1.30, growth 1% (input: historical EPS growth), PEG=30.68 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$22.380.80xyes√(22.5 × EPS $1.30 × BVPS $17.12) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$10.361.73xyesEPS $1.30 × (8.5 + 2×0.5%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$6.502.76xyesEPS $1.30 × (PEG 1.5 × growth 0.5% (input: historical EPS growth)) → PE 0.8x
Earnings YieldEarnings$14.051.28xyesEPS $1.30 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (dilution)6.7%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Capital allocation is where the Huntington story turns, because the bank has spent the last year buying scale and now has to prove it can return the proceeds. Management announced a $3 billion share repurchase authorization alongside Q1 results, a deliberate signal after a stretch of growth funded partly with stock. The Cadence and Veritex acquisitions lifted average loans 33% to $174.2 billion and average deposits 27% to $204.6 billion, and the funding side is the part that matters most for a bank. Deposits, not wholesale borrowings, carry the franchise, and Huntington describes net interest income, the gap between what it earns on loans and pays on deposits, as "our primary source of revenue". That gap widened last quarter: margin rose nine basis points to 3.24% as funding costs came down faster than asset yields.

The earnings engine underneath is improving toward what the price assumes. The market is paying about 1.2 times book and pricing in a return on equity near 12%; the bank has recently been earning around 9.7% on a GAAP basis, with acquisition charges still weighing on the reported line. Strip the integration costs and the underlying business is closer to the implied figure than the headline suggests, which is the bull's core point: the gap between earns-now and priced-in is mostly transition cost, not a structural earnings ceiling. As the Cadence and Veritex platforms move from cost center to contributor and the deal charges roll off, the reported return migrates toward the adjusted one.

Scale also buys franchise breadth. Huntington's loan book is granular rather than concentrated, with commercial real estate office exposure held to "$1.8 billion, or 1% of total loans and leases", a deliberately small footprint in the category that has scared bank investors most. That discipline matters because it lets the bank deploy the larger deposit base into auto, consumer, and middle-market commercial lending without carrying the office-CRE tail risk that has dogged peers. The bet is straightforward: a bigger, lower-cost deposit franchise running at a stable margin, with the repurchase authorization steadily retiring the shares that built it.

Bear Case

The advantage a regional bank guards most jealously is its deposit franchise, the pool of low-cost, sticky funding that lets it earn a spread, and that advantage is the one most exposed in Huntington's current shape. Deposit costs are not fixed; they reset with rates and with competition, and the 3.24% margin that looked healthy last quarter rests on funding costs falling faster than asset yields, a tailwind that reverses the moment depositors demand more for their cash. The bank's own filing frames the entire profit model around this spread between interest income and interest expense. When that spread is the moat, it is also the thing that erodes first, quietly, one repricing at a time.

The priced-in math is where the erosion shows up arithmetically. At today's price the market assumes Huntington sustains a return on equity around 12%, against the roughly 9.7% it has recently earned. That gap has to close, and it closes only if the acquired franchises deliver the cost savings and revenue the deals promised. History is not generous here: among banks earning this kind of return, only about 69% held it for a decade. If the return settles at the earns-now level instead of the implied one, the 1.2 times book the price supports compresses toward the value-oriented methods, which read the stock as expensive on trailing fundamentals. The bull thesis concedes the integration is unfinished; the bear's point is that unfinished integration is exactly when synergy targets slip.

Credit is the other place where scale cuts both ways. Huntington absorbed two loan books in quick succession, and acquired portfolios carry their own seasoning risk. The filing notes that loans showing "deterioration in credit quality since origination are classified as PCD loans" with an allowance established at acquisition, which is the accounting acknowledgment that some of what came in the door was already impaired. Commercial real estate beyond the small office slice remains a watch item; Huntington's own language is that the sector's recovery "is uneven by market and property type, and demand and property values continue to remain lower than normal." A bank that has just grown 33% into a still-normalizing credit cycle is taking on more of that uncertainty, not less, and the share count climbing 6.7% a year means each new provision is spread across more owners who paid for the growth.

Valuation

A bank is worth the return it earns on its capital, so the right lens here is price against book value, not an operating multiple. At about $16.88 (June 27, 2026) the market pays roughly 1.2 times book and is assuming Huntington sustains a return on equity near 12%. The bank has recently been earning around 9.7% on a GAAP basis, with acquisition charges still in the reported number. That is the whole valuation question in one line: the price is paying for a return the bank has not yet demonstrated post-deal, and the bet is that integration closes the gap.

The methods split cleanly on whether that bet is fair. Peer-multiple and growth-oriented approaches land at or above today's price, which is why the price looks justified through those lenses. The asset-value and earnings-power methods, which read the bank off its current book and current returns rather than its hoped-for ones, sit below the price. The relative-valuation read anchors on a sector P/E near 10 times. The spread between the two camps is the premium: the price credits the post-acquisition franchise, while the trailing-fundamentals methods credit only what the bank earns today. Where it sits in the cohort reinforces the cautious read, in the lower half of regional-bank price-to-book, which is the market discounting the integration risk rather than ignoring it.

Solvency does not read like an industrial company's, and it should not be forced to. For a deposit-funded balance sheet, debt is funding rather than corporate leverage, and operating cash flow follows loan flows, so net-debt and interest-coverage math do not apply. The frame that matters is capital return capacity, and there the signals are mixed in an instructive way: a fresh $3 billion repurchase authorization on one side, a share count rising about 6.7% a year on the other. The authorization is the tool to reverse the dilution that built the franchise; whether it does is the single thing a holder is underwriting at this price.

Catalysts

The defining recent event is the digestion of Cadence and Veritex, which together drove average loans up 33% year over year to $174.2 billion and average deposits up 27% to $204.6 billion. Reported Q1 2026 net income was $523 million, or $0.25 per diluted share, down from $0.30 the prior quarter as acquisition-related expenses hit the GAAP line. The cleaner read on the underlying business is that net interest income rose 33% year over year to roughly $1.91 billion fully-taxable equivalent, and net interest margin improved nine basis points to 3.24% as funding costs fell faster than asset yields.

The forward catalyst that matters most is capital return. Alongside Q1 results, Huntington authorized a new $3 billion share repurchase program, the mechanism by which the enlarged franchise converts into per-share value and reverses recent dilution. The pace of those buybacks, the trajectory of the net interest margin as deposit costs reset, and the seasoning of the acquired loan books are the three things to watch into the next earnings print. Organic balances grew about 1.5% excluding the acquired portfolios, the signal of whether the core franchise is still expanding on its own beyond the deals.

Peer Cohorts (Per Segment, With Filing Citations)

Consumer & Regional Banking (reported)

Commercial Banking (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

HBAN Q1 2026 earnings release · HBAN Q1 2026 earnings call, May 2026 · HBAN 8-K, Q1 2026

View the full interactive HBAN report on boothcheck